Dry skin therapy cream recalled over contamination found at the facility
DermaRite Industries is recalling 8,378 containers of Lantiseptic Dry Skin Therapy because it was made at the same facility where other products were found contaminated.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: Scored 2 as a precautionary recall: the record cites contamination found elsewhere in the facility rather than confirmed contamination of these lots or any reported harm.
Plain-English summary
Lantiseptic Dry Skin Therapy, Lanolin USP 30%, in 5 g, 4 oz and 14 oz tubes (NDCs 61924-504-05, 61924-504-04 and 61924-710-14), from DermaRite Industries of North Bergen, New Jersey, is being recalled for a CGMP deviation.
The recall follows the product being manufactured at the same facility where other products and lots were found to be contaminated.
The recall covers 8,378 containers across all lots with an expiry date on or before August 2027. The product was distributed nationwide in the United States. The FDA has classified the recall as Class II.
The enforcement record cites facility association rather than confirmed contamination of these lots, and reports no illnesses. Anyone holding an affected container should follow the firm's instructions.
The recalled product
- Product
- Lantiseptic, Dry Skin Therapy, Lanolin USP 30%, packaged in a) 5 g (0.17 oz) (NDC 61924-504-05), b) 4 oz (NDC 61924-504-04), and c)14 oz (NDC 61924-710-14) tubes, DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047.
- Manufacturer
- DermaRite Industries, LLC
- Category
- Drug — Topical
- Hazard
- cgmp-deviation
- facility-contamination
- precautionary
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots on or before expiry date 08/2027
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- ModerateQuality Choice Earwax Removal Kit Carbamide Peroxide Subpotent Drug Recall
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- ModerateLeader Carbamide Peroxide Earwax Removal Kit Recalled for Subpotency
FDA (Drugs) · 2026-07-22
- ModerateNystatin Cream Recall Due to Low Potency Test Results
FDA (Drugs) · 2026-07-22